Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia

Background The Barcelona Clinic Liver Cancer (BCLC) guidelines were updated in 2012, and a single large hepatocellular carcinoma (HCC) more than 5 cm was regarded as BCLC stage A rather than B in the updated version. In this study, we sought to re‐evaluate the outcomes of patients with HCC who under...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of surgical oncology 2020-12, Vol.122 (8), p.1587-1594
Hauptverfasser: Liu, Yueh‐Wei, Yong, Chee‐Chien, Lin, Chih‐Che, Wang, Chih‐Chi, Chen, Chao‐Long, Cheng, Yu‐Fan, Wang, Jing‐Houng, Yen, Yi‐Hao, Chen, Chien‐Hung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1594
container_issue 8
container_start_page 1587
container_title Journal of surgical oncology
container_volume 122
creator Liu, Yueh‐Wei
Yong, Chee‐Chien
Lin, Chih‐Che
Wang, Chih‐Chi
Chen, Chao‐Long
Cheng, Yu‐Fan
Wang, Jing‐Houng
Yen, Yi‐Hao
Chen, Chien‐Hung
description Background The Barcelona Clinic Liver Cancer (BCLC) guidelines were updated in 2012, and a single large hepatocellular carcinoma (HCC) more than 5 cm was regarded as BCLC stage A rather than B in the updated version. In this study, we sought to re‐evaluate the outcomes of patients with HCC who underwent liver resection (LR) within (stage 0 and A) and beyond (stage B and C) the BCLC guideline recommendations of the updated BCLC staging system. Methods This retrospective study enrolled 774 consecutive patients with naïve HCC who underwent LR from 2011 to 2018 at our institution. The overall survival (OS) and recurrence‐free survival (RFS) of these patients were examined. Results Of the patients, 606 had BCLC stage 0 or A HCC, and 168 had BCLC stage B or C HCC. The 5‐year OS and RFS among the patients within the BCLC criteria for LR were 75.2% and 56.1%, respectively, vs 54.9% and 34.0%, respectively, among the patients beyond the BCLC criteria (P 
doi_str_mv 10.1002/jso.26183
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2435756525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2471553306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-51f15ac0746a6d17de60ffc41a558ce491a381fb2a6c802d56abe8a5492ddcee3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EokNhwQsgS2xgkdZ2Yidh145KAY1UiZ91dMe5mXjk2IOdtJodj8Dr8Do8ST1N6aISqyP7fjrn6h5CXnN2whkTp9voT4TiVf6ELDirVVazunpKFmkmsqKs2RF5EeOWMVbXqnhOjnJRccmrekH-rMw1Bhowoh6Nd9R3tMcdjF6jtZOFQDUEbZwfgN6YsTeOgmvpGvc-ydgjPU9ztN4BXVrjjKaz5RKcTrKZTIvpH1OG9sOAroVDUPxAv2Kc7BhpF_xAgfZm0__99fva22lAau9M4hQ2GPZUoxvTM4VfQBzpWTTwkjzrwEZ8da_H5MfHi-_LT9nq6vLz8myV6VzmeSZ5xyVoVhYKVMvLFhXrOl1wkLLSWNQc8op3awFKV0y0UsEaK5BFLdpWI-bH5N3suwv-54RxbAYTD8cBh36KjShyWUolhUzo20fo1k_Bpe0SVXKZ9mEqUe9nSgcfY8Cu2QUzQNg3nDWHPpvUZ3PXZ2Lf3DtO6wHbB_JfgQk4nYEbY3H_f6fmy7er2fIWbgGuxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471553306</pqid></control><display><type>article</type><title>Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Liu, Yueh‐Wei ; Yong, Chee‐Chien ; Lin, Chih‐Che ; Wang, Chih‐Chi ; Chen, Chao‐Long ; Cheng, Yu‐Fan ; Wang, Jing‐Houng ; Yen, Yi‐Hao ; Chen, Chien‐Hung</creator><creatorcontrib>Liu, Yueh‐Wei ; Yong, Chee‐Chien ; Lin, Chih‐Che ; Wang, Chih‐Chi ; Chen, Chao‐Long ; Cheng, Yu‐Fan ; Wang, Jing‐Houng ; Yen, Yi‐Hao ; Chen, Chien‐Hung</creatorcontrib><description>Background The Barcelona Clinic Liver Cancer (BCLC) guidelines were updated in 2012, and a single large hepatocellular carcinoma (HCC) more than 5 cm was regarded as BCLC stage A rather than B in the updated version. In this study, we sought to re‐evaluate the outcomes of patients with HCC who underwent liver resection (LR) within (stage 0 and A) and beyond (stage B and C) the BCLC guideline recommendations of the updated BCLC staging system. Methods This retrospective study enrolled 774 consecutive patients with naïve HCC who underwent LR from 2011 to 2018 at our institution. The overall survival (OS) and recurrence‐free survival (RFS) of these patients were examined. Results Of the patients, 606 had BCLC stage 0 or A HCC, and 168 had BCLC stage B or C HCC. The 5‐year OS and RFS among the patients within the BCLC criteria for LR were 75.2% and 56.1%, respectively, vs 54.9% and 34.0%, respectively, among the patients beyond the BCLC criteria (P &lt; .001). Alpha‐fetoprotein more than 400 ng/mL (hazard ratio = 2.06, 95% confidence interval, 1.31‐3.26, P = .002) was the only independent variable associated with recurrence among the patients beyond the BCLC criteria. Conclusions LR provided acceptable outcomes among selected patients with BCLC stage B and C HCC.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.26183</identifier><identifier>PMID: 32815189</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Barcelona Clinic Liver Cancer ; Carcinoma, Hepatocellular - epidemiology ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Far East - epidemiology ; Female ; Follow-Up Studies ; Hepatectomy ; Hepatectomy - methods ; hepatocellular carcinoma ; Hospitals, High-Volume - statistics &amp; numerical data ; Humans ; Liver cancer ; Liver Neoplasms - epidemiology ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; liver resection ; Male ; Middle Aged ; Neoplasm Recurrence, Local - epidemiology ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Patient Selection ; Practice Guidelines as Topic - standards ; Prognosis ; Retrospective Studies</subject><ispartof>Journal of surgical oncology, 2020-12, Vol.122 (8), p.1587-1594</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-51f15ac0746a6d17de60ffc41a558ce491a381fb2a6c802d56abe8a5492ddcee3</citedby><cites>FETCH-LOGICAL-c3533-51f15ac0746a6d17de60ffc41a558ce491a381fb2a6c802d56abe8a5492ddcee3</cites><orcidid>0000-0001-6251-7230</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjso.26183$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjso.26183$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32815189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yueh‐Wei</creatorcontrib><creatorcontrib>Yong, Chee‐Chien</creatorcontrib><creatorcontrib>Lin, Chih‐Che</creatorcontrib><creatorcontrib>Wang, Chih‐Chi</creatorcontrib><creatorcontrib>Chen, Chao‐Long</creatorcontrib><creatorcontrib>Cheng, Yu‐Fan</creatorcontrib><creatorcontrib>Wang, Jing‐Houng</creatorcontrib><creatorcontrib>Yen, Yi‐Hao</creatorcontrib><creatorcontrib>Chen, Chien‐Hung</creatorcontrib><title>Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia</title><title>Journal of surgical oncology</title><addtitle>J Surg Oncol</addtitle><description>Background The Barcelona Clinic Liver Cancer (BCLC) guidelines were updated in 2012, and a single large hepatocellular carcinoma (HCC) more than 5 cm was regarded as BCLC stage A rather than B in the updated version. In this study, we sought to re‐evaluate the outcomes of patients with HCC who underwent liver resection (LR) within (stage 0 and A) and beyond (stage B and C) the BCLC guideline recommendations of the updated BCLC staging system. Methods This retrospective study enrolled 774 consecutive patients with naïve HCC who underwent LR from 2011 to 2018 at our institution. The overall survival (OS) and recurrence‐free survival (RFS) of these patients were examined. Results Of the patients, 606 had BCLC stage 0 or A HCC, and 168 had BCLC stage B or C HCC. The 5‐year OS and RFS among the patients within the BCLC criteria for LR were 75.2% and 56.1%, respectively, vs 54.9% and 34.0%, respectively, among the patients beyond the BCLC criteria (P &lt; .001). Alpha‐fetoprotein more than 400 ng/mL (hazard ratio = 2.06, 95% confidence interval, 1.31‐3.26, P = .002) was the only independent variable associated with recurrence among the patients beyond the BCLC criteria. Conclusions LR provided acceptable outcomes among selected patients with BCLC stage B and C HCC.</description><subject>Aged</subject><subject>Barcelona Clinic Liver Cancer</subject><subject>Carcinoma, Hepatocellular - epidemiology</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Far East - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hepatectomy</subject><subject>Hepatectomy - methods</subject><subject>hepatocellular carcinoma</subject><subject>Hospitals, High-Volume - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - epidemiology</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>liver resection</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Patient Selection</subject><subject>Practice Guidelines as Topic - standards</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EokNhwQsgS2xgkdZ2Yidh145KAY1UiZ91dMe5mXjk2IOdtJodj8Dr8Do8ST1N6aISqyP7fjrn6h5CXnN2whkTp9voT4TiVf6ELDirVVazunpKFmkmsqKs2RF5EeOWMVbXqnhOjnJRccmrekH-rMw1Bhowoh6Nd9R3tMcdjF6jtZOFQDUEbZwfgN6YsTeOgmvpGvc-ydgjPU9ztN4BXVrjjKaz5RKcTrKZTIvpH1OG9sOAroVDUPxAv2Kc7BhpF_xAgfZm0__99fva22lAau9M4hQ2GPZUoxvTM4VfQBzpWTTwkjzrwEZ8da_H5MfHi-_LT9nq6vLz8myV6VzmeSZ5xyVoVhYKVMvLFhXrOl1wkLLSWNQc8op3awFKV0y0UsEaK5BFLdpWI-bH5N3suwv-54RxbAYTD8cBh36KjShyWUolhUzo20fo1k_Bpe0SVXKZ9mEqUe9nSgcfY8Cu2QUzQNg3nDWHPpvUZ3PXZ2Lf3DtO6wHbB_JfgQk4nYEbY3H_f6fmy7er2fIWbgGuxw</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Liu, Yueh‐Wei</creator><creator>Yong, Chee‐Chien</creator><creator>Lin, Chih‐Che</creator><creator>Wang, Chih‐Chi</creator><creator>Chen, Chao‐Long</creator><creator>Cheng, Yu‐Fan</creator><creator>Wang, Jing‐Houng</creator><creator>Yen, Yi‐Hao</creator><creator>Chen, Chien‐Hung</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6251-7230</orcidid></search><sort><creationdate>20201201</creationdate><title>Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia</title><author>Liu, Yueh‐Wei ; Yong, Chee‐Chien ; Lin, Chih‐Che ; Wang, Chih‐Chi ; Chen, Chao‐Long ; Cheng, Yu‐Fan ; Wang, Jing‐Houng ; Yen, Yi‐Hao ; Chen, Chien‐Hung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-51f15ac0746a6d17de60ffc41a558ce491a381fb2a6c802d56abe8a5492ddcee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Barcelona Clinic Liver Cancer</topic><topic>Carcinoma, Hepatocellular - epidemiology</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Far East - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hepatectomy</topic><topic>Hepatectomy - methods</topic><topic>hepatocellular carcinoma</topic><topic>Hospitals, High-Volume - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - epidemiology</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>liver resection</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Patient Selection</topic><topic>Practice Guidelines as Topic - standards</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yueh‐Wei</creatorcontrib><creatorcontrib>Yong, Chee‐Chien</creatorcontrib><creatorcontrib>Lin, Chih‐Che</creatorcontrib><creatorcontrib>Wang, Chih‐Chi</creatorcontrib><creatorcontrib>Chen, Chao‐Long</creatorcontrib><creatorcontrib>Cheng, Yu‐Fan</creatorcontrib><creatorcontrib>Wang, Jing‐Houng</creatorcontrib><creatorcontrib>Yen, Yi‐Hao</creatorcontrib><creatorcontrib>Chen, Chien‐Hung</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yueh‐Wei</au><au>Yong, Chee‐Chien</au><au>Lin, Chih‐Che</au><au>Wang, Chih‐Chi</au><au>Chen, Chao‐Long</au><au>Cheng, Yu‐Fan</au><au>Wang, Jing‐Houng</au><au>Yen, Yi‐Hao</au><au>Chen, Chien‐Hung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J Surg Oncol</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>122</volume><issue>8</issue><spage>1587</spage><epage>1594</epage><pages>1587-1594</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Background The Barcelona Clinic Liver Cancer (BCLC) guidelines were updated in 2012, and a single large hepatocellular carcinoma (HCC) more than 5 cm was regarded as BCLC stage A rather than B in the updated version. In this study, we sought to re‐evaluate the outcomes of patients with HCC who underwent liver resection (LR) within (stage 0 and A) and beyond (stage B and C) the BCLC guideline recommendations of the updated BCLC staging system. Methods This retrospective study enrolled 774 consecutive patients with naïve HCC who underwent LR from 2011 to 2018 at our institution. The overall survival (OS) and recurrence‐free survival (RFS) of these patients were examined. Results Of the patients, 606 had BCLC stage 0 or A HCC, and 168 had BCLC stage B or C HCC. The 5‐year OS and RFS among the patients within the BCLC criteria for LR were 75.2% and 56.1%, respectively, vs 54.9% and 34.0%, respectively, among the patients beyond the BCLC criteria (P &lt; .001). Alpha‐fetoprotein more than 400 ng/mL (hazard ratio = 2.06, 95% confidence interval, 1.31‐3.26, P = .002) was the only independent variable associated with recurrence among the patients beyond the BCLC criteria. Conclusions LR provided acceptable outcomes among selected patients with BCLC stage B and C HCC.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32815189</pmid><doi>10.1002/jso.26183</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6251-7230</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2020-12, Vol.122 (8), p.1587-1594
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_miscellaneous_2435756525
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Barcelona Clinic Liver Cancer
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Far East - epidemiology
Female
Follow-Up Studies
Hepatectomy
Hepatectomy - methods
hepatocellular carcinoma
Hospitals, High-Volume - statistics & numerical data
Humans
Liver cancer
Liver Neoplasms - epidemiology
Liver Neoplasms - pathology
Liver Neoplasms - surgery
liver resection
Male
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - surgery
Patient Selection
Practice Guidelines as Topic - standards
Prognosis
Retrospective Studies
title Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T18%3A34%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20resection%20of%20hepatocellular%20carcinoma%20within%20and%20beyond%20the%20Barcelona%20Clinic%20Liver%20Cancer%20guideline%20recommendations:%20Results%20from%20a%20high%E2%80%90volume%20liver%20surgery%20center%20in%20East%20Asia&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Liu,%20Yueh%E2%80%90Wei&rft.date=2020-12-01&rft.volume=122&rft.issue=8&rft.spage=1587&rft.epage=1594&rft.pages=1587-1594&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.26183&rft_dat=%3Cproquest_cross%3E2471553306%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471553306&rft_id=info:pmid/32815189&rfr_iscdi=true